Ovarian Cancer | Tumor

CURE’s ovarian cancer page is a go-to resource for oncology news and updates in the world of ovarian cancer Here, readers will find cancer articles, videos, podcasts, and more with expert insight into the latest treatments and research in ovarian cancer.

Regaining Independence After Ovarian Cancer Surgery

July 17th 2025, 8:00pm

Video

After ovarian cancer surgery, Mary Barbera spent three months in rehab before finally returning home, a milestone that marked her emotional recovery.

New Trials Target Brain, Bladder, Ovarian and Other Cancers

July 7th 2025, 8:09pm

Article

New clinical trials are advancing in hard-to-treat cancers, offering targeted and less toxic options for patients with limited treatment paths.

How Love Helped Me Overcome my Cancer Diagnosis

June 12th 2025, 7:00pm

Article

Facing two life-threatening diagnoses, I overcame fear of self-injections by leaning on love, encouragement and determination to save my life.

FDA Grants Fast Track Status to PHST001 for Ovarian Cancer Treatment

June 10th 2025, 3:18pm

Article

The FDA grants fast track designation to PHST001, an antibody targeting CD24, for advanced platinum-resistant and platinum-sensitive ovarian cancer.

Ovarian Cancer Treatment Side Effects Make for a Difficult Balancing Act

May 23rd 2025, 5:00pm

Article

I urge researchers to look into why side effects occur in cancer drugs and to find ways to mitigate them that doesn’t impact their efficacy.

The OVATION 3 Study Initiates First Trial Site for Ovarian Cancer

May 8th 2025, 7:00pm

Article

The first trial site has been initiated in the pivotal phase 3 OVATION 3 study which will investigate IMNN-001 for newly diagnosed advanced ovarian cancer.

Nurse’s Big Personality Makes Cancer Treatment More Bearable.

May 6th 2025, 5:00pm

Article

She wore a variety of bright sneakers and occasionally did a cha-cha-cha in them. Her laughter was contagious. Patients smiled. The other nurses smiled.

First Patient Dosed With Azenosertib in Cyclin E1+ Ovarian Cancer

May 2nd 2025, 4:00pm

Article

The first patient with Cyclin E1+ platinum-resistant ovarian cancer has been dosed with azenosertib in part 2a of the phase 2 DENALI clinical trial.

FDA Fast Tracks INX-315 for Tough-to-Treat Ovarian Cancer

April 29th 2025, 3:00pm

Article

INX-315, a CDK2 inhibitor, received FDA fast track designation for patients with CCNE1-amplified platinum-resistant ovarian cancer.

Breaking Down The Use of Rina-S in Advanced Ovarian Cancer

April 16th 2025, 8:00pm

Video

Dr. Elizabeth K. Lee discusses the RAINFOL-01 clinical trial evaluating treatment with Rina-S in advanced ovarian cancer.